Naba Alsaha Medical Services Company

TADAWUL:9546.SR

65.1 (SAR) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q42024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q1
Revenue 98.00948.13648.13650.25650.25681.84140.9266.78633.39362.89831.44961.11930.5656.56228.281
Cost of Revenue 67.17432.37232.37231.18431.18448.20724.10342.48122.1235.56417.78237.49119.45533.40816.704
Gross Profit 30.83515.76515.76519.07219.07233.63416.81724.30511.27327.33513.66723.62911.10523.15511.577
Gross Profit Ratio 0.3150.3280.3280.380.380.4110.4110.3640.3380.4350.4350.3870.3630.4090.409
Reseach & Development Expenses 000000000000000
General & Administrative Expenses 08.428.425.7985.7987.4887.4884.84.85.8455.8453.2923.2924.494.49
Selling & Marketing Expenses 0000.5470.5477.48800.2490.2495.84500.6260.6264.490
SG&A 21.0018.428.426.486.4814.9767.48811.6394.19311.695.84510.8314.2828.984.49
Other Expenses 0000.43800000000000
Operating Expenses 21.0018.428.426.9186.03614.9762.31811.6394.85111.695.51610.8314.7428.984.051
Operating Income 9.8347.3457.34512.15412.59218.6589.32912.6667.0815.6457.82312.7986.82314.1747.087
Operating Income Ratio 0.10.1530.1530.2420.2510.2280.2280.190.2120.2490.2490.2090.2230.2510.251
Total Other Income Expenses Net 1.599-0.092-0.0920.8180.81810.5685.130.1980.0350.5530.277-0.19-0.0950.7460.373
Income Before Tax 11.4337.2537.25312.97212.97229.22614.45912.8646.36816.1988.09912.6086.30414.9217.46
Income Before Tax Ratio 0.1170.1510.1510.2580.2580.3570.3530.1930.1910.2580.2580.2060.2060.2640.264
Income Tax Expense 1.8110.7310.7310.6650.6651.1490.5751.2060.6030.8050.4031.0120.5060.6890.344
Net Income 8.7416.5226.52212.30712.30727.76913.88511.535.76515.3937.69611.5955.79814.2327.116
Net Income Ratio 0.0890.1350.1350.2450.2450.3390.3390.1730.1730.2450.2450.190.190.2520.252
EPS 0.830.620.621.171.172.641.321.10.551.470.731.10.551.360.68
EPS Diluted 0.830.620.621.171.172.641.321.10.551.470.731.10.551.360.68
EBITDA 17.5069.7059.70514.48914.48934.1111.27316.5718.419.6019.10216.0698.06917.9488.165
EBITDA Ratio 0.1790.2020.2020.2880.2880.4170.2750.2480.2520.3120.2890.2630.2640.3170.289